Introduction
Vitamin D is a fat soluble vitamin. It is a steroid hormone that is essential for calcium and phosphate metabolism. It is naturally present in very few foods. It is produced endogenously by ultraviolet light which strikes the skin and gives vitamin D thus making it unique among all vitamins (1) .This combined with its ability to act on specific target tissues and receptors makes its classification as a steroid hormone more appropriate. Stroke is a sudden onset of focal neurological deficit, a major cause of morbidity and mortality and the second leading cause of death worldwide (2) . Stroke has a heterogeneous etiology, caused by modifiable and un-modifiable risk factors. Recent studies have strongly suggested an association of deficiency of 25-hydroxyvitamin D with ischemic stroke (3, 4) and cardiovascular disease (5.6) . Most common forms of Vitamin D in humans are vitamin D3 (cholecalciferol) and Vitamin D2 (ergocalciferol) (3) . bone loss and hip fracture (7) and its prevalence is high in both hemispheric populations (8) . Serum 25-hydroxyvitamin D is the circulating form of vitamin D with a half life of 2 to 3 weeks and is converted to the active form -1,25-dihydroxy vitamin D3 in the kidneys (9) . 25-hydroxyvitamin D is a marker of vitamin D status in the human body (10, 11) . Some population based studies have shown that 40% -45% of Indians have 25-hydroxyvitamin D deficiency in India (12) . The study aim to investigate the association between serum 25-hydroxyvitamin D deficiency in ischemic as well as hemorrhagic stroke patients. (15) . Substantia nigra has the highest density of vitamin D receptors 
Vitamin D and Role in CNS

Materials and Methods
Methods of Statistical Analysis
Data tabulation and analysis using tests such as unpaired t test for the parametric dataand chi square test and Mann Whitney U test for non parametric data, along with other statistical tests will be applied based on the need, based on these to draw appropriate conclusions and graph recommendation merited.
Results
This study included 100 patients , of which 50 cases were stroke cases (ischemic and hemorrhagic) and 50 were controls, admitted in Department of General Medicine, Kempegowda Institute of Medical Sciences, Bangalore between December 2014 to June 2016. The mean age of controls was 61.5 years and that of cases was 63.8 years. The number of males and females in the control group was 30 and 20 respectively, whereas in the case group there were 28 males and 22 females. Among the controls and cases , the prevalence of vitamin D deficiency among stroke patients(cases) was 56% while 14% patients were found to have insufficient levels of vitamin D and 30% were found to have sufficient vitamin D levels. Vitamin D deficiency among controls was 12% while 20% controls were found to have insufficient levels of vitamin d and 68% were found to have sufficient levels of vitamin D. The prevalence of vitamin D deficiency in ischemic stroke was 57.60% as compared to hemorrhagic stroke where it was 52.90%. The prevalence of vitamin D deficiency in our study was found to be statistically significant in stroke patients (p<0.001) vs the controls with an chi square value of 12.960. This corroborates the fact that vitamin D deficiency is an independent risk factor for both ischemic as well as hemorrhagic stroke.
Graph 1 Distribution of Vitamin D Levels among the Study Group
This Graph shows distribution of vitamin D levels among the study groups. In the controls group, 68% had vitamin D sufficient levels,20% had vitamin D insufficient levels and 12% had vitamin D deficiency.
In case group, 30% had vitamin D sufficient levels, 14% had vitamin D insufficient levels and 56% had vitamin D deficiency.
Graph 2-Comparison of Mean Vitamin D Values among Study Group
This graph compares mean vitamin D value among control group and case group. In control group, mean vitamin D value was 29.15ng/ml and in case group mean vitamin D value was 19.84ng/ml. showed an independent association of 25-hydroxyvitamin D deficiency with ischemic stroke (odds ratio: 1.6; 95% CI 1.2-2.8). The association was strongest with large artery atherosclerosis (odds ratio: 2.4; 95% CI 1.6-3.5) and cardioembolic stroke (odds ratio: 2.0; 95% CI 1.0-3.2). They found that 25-hydroxyvitamin D deficiency had an independent association with ischemic stroke. Though our results are further supported by the a forementioned studies, the prevalence of vitamin D deficiency in our study was more in case of haemorrhagic stroke (57.60% vs 42.8% in the above study) (13) . In a study conducted by An Pan et al. (2012) entitled 25-hydroxyvitamin D levels and risk of stroke: A prospective study and meta-analysis. The study measured 25(OH)D levels among 464 women who developed ischemic stroke and an equal number of controls who were free of stroke through 2006 in the Nurses' Health Study (NHS). The study searched MEDLINE and EMBASE for articles published through March 2011 that prospectively evaluated 25(OH)D levels in relation to stroke. After multivariable adjustment for lifestyle and dietary covariates, lower 25(OH) D levels were associated with an elevated risk of ischemic stroke in the NHS: the odds ratio (95% CI) comparing women in the lowest vs. highest tertiles was 1.49 (1.01, 2.18; Ptrend=0.04). We found 6 other prospective studies that examined 25 (OH)D in relation to stroke outcomes. After pooling our results with these prospective studies that included 1,214 stroke cases in total, low 25(OH)D levels were associated with increased risk of developing stroke outcomes in comparison to high levels: the pooled relative risk (95% CI) was 1.52 (1.20, 1.85; I2 = 0.0%, Pheterogeneity=0.63). In two studies that explicitly examined ischemic stroke, this association was 1.59 (1.07, 2.12; I2 = 0.0%, Pheterogeneity=0.80). In this study these data provide evidence that low vitamin D levels are modestly associated with risk of stroke. Maintaining adequate vitamin D status may lower risk of stroke in women (14) .
Graph 3-
Conclusion
It was found that there was a significant association between low serum vitamin D levels and risk of both ischemic as well as hemorrhagic stroke. The prevalence of vitamin D deficiency in ischemic stroke was 57.60% as compared to hemorrhagic stroke where it was 52.90%. In control group, mean vitamin d value was 29.15ng/ml and in case group mean vitamin d value was 19.84ng/ml. A single serum measurement of vitamin D could be a useful marker in predicting future outcomes in respect to stroke. So early identification and correction of vitamin D deficiency can be an important tool to reduce the incidence of Stroke.
